These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 11889043)

  • 1. Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.
    Masternak K; Reith W
    EMBO J; 2002 Mar; 21(6):1379-88. PubMed ID: 11889043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
    Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
    J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transcription factor RFX protects MHC class II genes against epigenetic silencing by DNA methylation.
    Seguín-Estévez Q; De Palma R; Krawczyk M; Leimgruber E; Villard J; Picard C; Tagliamacco A; Abbate G; Gorski J; Nocera A; Reith W
    J Immunol; 2009 Aug; 183(4):2545-53. PubMed ID: 19620312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long distance control of MHC class II expression by multiple distal enhancers regulated by regulatory factor X complex and CIITA.
    Krawczyk M; Peyraud N; Rybtsova N; Masternak K; Bucher P; Barras E; Reith W
    J Immunol; 2004 Nov; 173(10):6200-10. PubMed ID: 15528357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.
    Masternak K; Muhlethaler-Mottet A; Villard J; Zufferey M; Steimle V; Reith W
    Genes Dev; 2000 May; 14(9):1156-66. PubMed ID: 10809673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CIITA coordinates multiple histone acetylation modifications at the HLA-DRA promoter.
    Beresford GW; Boss JM
    Nat Immunol; 2001 Jul; 2(7):652-7. PubMed ID: 11429551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes.
    Villard J; Muhlethaler-Mottet A; Bontron S; Mach B; Reith W
    Int Immunol; 1999 Mar; 11(3):461-9. PubMed ID: 10221658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X box-like sequences in the MHC class II region maintain regulatory function.
    Gomez JA; Majumder P; Nagarajan UM; Boss JM
    J Immunol; 2005 Jul; 175(2):1030-40. PubMed ID: 16002703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.
    Zika E; Greer SF; Zhu XS; Ting JP
    Mol Cell Biol; 2003 May; 23(9):3091-102. PubMed ID: 12697811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatin remodeling and extragenic transcription at the MHC class II locus control region.
    Masternak K; Peyraud N; Krawczyk M; Barras E; Reith W
    Nat Immunol; 2003 Feb; 4(2):132-7. PubMed ID: 12524537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordinated changes of histone modifications and HDAC mobilization regulate the induction of MHC class II genes by Trichostatin A.
    Gialitakis M; Kretsovali A; Spilianakis C; Kravariti L; Mages J; Hoffmann R; Hatzopoulos AK; Papamatheakis J
    Nucleic Acids Res; 2006; 34(3):765-72. PubMed ID: 16452299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
    Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
    Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction.
    Chin KC; Mao C; Skinner C; Riley JL; Wright KL; Moreno CS; Stark GR; Boss JM; Ting JP
    Immunity; 1994 Nov; 1(8):687-97. PubMed ID: 7600294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation.
    Hake SB; Masternak K; Kammerbauer C; Janzen C; Reith W; Steimle V
    Mol Cell Biol; 2000 Oct; 20(20):7716-25. PubMed ID: 11003667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple interactions between BRG1 and MHC class II promoter binding proteins.
    Mudhasani R; Fontes JD
    Mol Immunol; 2005 Apr; 42(6):673-82. PubMed ID: 15781111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay among coactivator-associated arginine methyltransferase 1, CBP, and CIITA in IFN-gamma-inducible MHC-II gene expression.
    Zika E; Fauquier L; Vandel L; Ting JP
    Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16321-6. PubMed ID: 16254053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assembly of major histocompatibility complex (MHC) class II transcription factors: association and promoter recognition of RFX proteins.
    Burd AL; Ingraham RH; Goldrick SE; Kroe RR; Crute JJ; Grygon CA
    Biochemistry; 2004 Oct; 43(40):12750-60. PubMed ID: 15461447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of class II transcriptional activator-induced genes by representational difference analysis: discoordinate regulation of the DN alpha/DO beta heterodimer.
    Taxman DJ; Cressman DE; Ting JP
    J Immunol; 2000 Aug; 165(3):1410-6. PubMed ID: 10903745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The DMB promoter: delineation, in vivo footprint, trans-activation, and trans-dominant suppression.
    Ting JP; Wright KL; Chin KC; Brickey WJ; Li G
    J Immunol; 1997 Dec; 159(11):5457-62. PubMed ID: 9548486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DMA and HLA-DMB gene expression functions through the conserved S-X-Y region.
    Westerheide SD; Louis-Plence P; Ping D; He XF; Boss JM
    J Immunol; 1997 May; 158(10):4812-21. PubMed ID: 9144496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.